These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Imbalances between the levels of tissue factor and tissue factor pathway inhibitor in ARDS patients. Gando S; Kameue T; Matsuda N; Hayakawa M; Morimoto Y; Ishitani T; Kemmotsu O Thromb Res; 2003 Jan; 109(2-3):119-24. PubMed ID: 12706640 [TBL] [Abstract][Full Text] [Related]
5. Systemic inflammation and disseminated intravascular coagulation in early stage of ALI and ARDS: role of neutrophil and endothelial activation. Gando S; Kameue T; Matsuda N; Sawamura A; Hayakawa M; Kato H Inflammation; 2004 Aug; 28(4):237-44. PubMed ID: 15673166 [TBL] [Abstract][Full Text] [Related]
6. Effects of sivelestat on bronchial inflammatory responses after esophagectomy. Yamaguchi K; Sugasawa Y; Takeuchi K; Kugimiya T; Kumakura S; Iwanuma Y; Kajiyama Y; Tsurumaru M; Nagaoka I; Inada E Int J Mol Med; 2011 Aug; 28(2):187-92. PubMed ID: 21567070 [TBL] [Abstract][Full Text] [Related]
7. Clinical effects of a neutrophil elastase inhibitor, sivelestat, in patients with acute respiratory distress syndrome. Okayama N; Kakihana Y; Setoguchi D; Imabayashi T; Omae T; Matsunaga A; Kanmura Y J Anesth; 2006; 20(1):6-10. PubMed ID: 16421669 [TBL] [Abstract][Full Text] [Related]
8. Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis. Miyoshi S; Hamada H; Ito R; Katayama H; Irifune K; Suwaki T; Nakanishi N; Kanematsu T; Dote K; Aibiki M; Okura T; Higaki J Drug Des Devel Ther; 2013; 7():305-16. PubMed ID: 23596346 [TBL] [Abstract][Full Text] [Related]
9. Neutrophil elastase and acute lung injury: prospects for sivelestat and other neutrophil elastase inhibitors as therapeutics. Zeiher BG; Matsuoka S; Kawabata K; Repine JE Crit Care Med; 2002 May; 30(5 Suppl):S281-7. PubMed ID: 12004249 [TBL] [Abstract][Full Text] [Related]
10. Usefulness of a selective neutrophil elastase inhibitor (sivelestat) in septic ARDS patients after gastrointestinal surgery. Togo S; Matsuo K; Ishibe A; Nagano Y; Takahashi M; Mochizuki H; Osada S; Kameda K; Shimada H Hepatogastroenterology; 2008; 55(84):967-73. PubMed ID: 18705309 [TBL] [Abstract][Full Text] [Related]
12. [Prognostic significance of neutrophil elastase inhibitor in patients with acute lung injury and interstitial pneumonia]. Sato N; Sutani A; Oya H; Yamaguchi T; Saito K; Kobayashi K; Nagata M; Hagiwara K; Kanazawa M Nihon Kokyuki Gakkai Zasshi; 2007 Mar; 45(3):237-42. PubMed ID: 17419435 [TBL] [Abstract][Full Text] [Related]
13. Infections and the inflammatory response in acute respiratory distress syndrome. Headley AS; Tolley E; Meduri GU Chest; 1997 May; 111(5):1306-21. PubMed ID: 9149588 [TBL] [Abstract][Full Text] [Related]
14. Relationship between neutrophil elastase and acute lung injury in humans. Tamakuma S; Ogawa M; Aikawa N; Kubota T; Hirasawa H; Ishizaka A; Taenaka N; Hamada C; Matsuoka S; Abiru T Pulm Pharmacol Ther; 2004; 17(5):271-9. PubMed ID: 15477122 [TBL] [Abstract][Full Text] [Related]
15. Effect of a polymorphonuclear elastase inhibitor (sivelestat sodium) on acute lung injury after cardiopulmonary bypass: findings of a double-blind randomized study. Ryugo M; Sawa Y; Takano H; Matsumiya G; Iwai S; Ono M; Hata H; Yamauchi T; Nishimura M; Fujino Y; Matsuda H Surg Today; 2006; 36(4):321-6. PubMed ID: 16554988 [TBL] [Abstract][Full Text] [Related]
16. Administration of a specific inhibitor of neutrophil elastase attenuates pulmonary fibrosis after acute lung injury in mice. Fujino N; Kubo H; Suzuki T; He M; Suzuki T; Yamada M; Takahashi T; Ota C; Yamaya M Exp Lung Res; 2012 Feb; 38(1):28-36. PubMed ID: 22148910 [TBL] [Abstract][Full Text] [Related]
17. [Efficacy of sivelestat for acute lung injury due to severe bacterial pneumonia with systemic inflammatory response syndrome]. Nakamura S; Yanagihara K; Izumikawa K; Seki M; Kakeya H; Yamamoto Y; Mukae H; Tashiro T; Kohno S Nihon Kokyuki Gakkai Zasshi; 2008 Oct; 46(10):793-7. PubMed ID: 19044028 [TBL] [Abstract][Full Text] [Related]
18. Reevaluation of the efficacy and safety of the neutrophil elastase inhibitor, Sivelestat, for the treatment of acute lung injury associated with systemic inflammatory response syndrome; a phase IV study. Aikawa N; Ishizaka A; Hirasawa H; Shimazaki S; Yamamoto Y; Sugimoto H; Shinozaki M; Taenaka N; Endo S; Ikeda T; Kawasaki Y Pulm Pharmacol Ther; 2011 Oct; 24(5):549-54. PubMed ID: 21540122 [TBL] [Abstract][Full Text] [Related]
19. Plasma elastase levels and the development of the adult respiratory distress syndrome. Donnelly SC; MacGregor I; Zamani A; Gordon MW; Robertson CE; Steedman DJ; Little K; Haslett C Am J Respir Crit Care Med; 1995 May; 151(5):1428-33. PubMed ID: 7735596 [TBL] [Abstract][Full Text] [Related]
20. Pilot study of the effects of ONO-5046 in patients with acute respiratory distress syndrome. Kadoi Y; Hinohara H; Kunimoto F; Saito S; Goto F; Kosaka T; Ieta K Anesth Analg; 2004 Sep; 99(3):872-877. PubMed ID: 15333424 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]